Illumina advances preventive genomics through strategic consortium with Veritas Genetics

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO, March 16, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks